UK Biobank operates one of the most sensitive databases in biomedical research: genetic, lifestyle, and health records from half a million participants, aggregated over 15 years of follow-up. The resource is accessed by over 22,000 approved researchers across more than 60 countries. The threat model is specific - protecting deeply personal genomic and medical data at population scale while maintaining an open-access platform for global scientific use.
The security challenge here isn't just perimeter defense on a typical corporate network. It's safeguarding a biomedical database where the data itself - DNA sequences, imaging scans, linked medical records - can never be re-identified once exposed. The technical domains span biomedical database management and health informatics, meaning the team works at the intersection of large-scale data infrastructure and the regulatory frameworks governing human subject research. Systems must be engineered to allow controlled access without creating vectors for bulk exfiltration.
UK Biobank is based in the United Kingdom and operates as a research resource supporting work in epidemiology, genetic research, and public health. The platform's open-access model - granting data access to approved researchers globally - means the security posture has to account for a continuously expanding user base across 60+ countries, each with different institutional security standards. Building and maintaining that trust is the job.
